IQV IQVIA
company
SEC Filings & Insider Trading Activity 2026

CIK: 1478242
Industrials
Services-Commercial Physical & Biological Research 55 filings
S&P 500

Latest IQVIA (IQV) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 17, 2026, a 10-Q quarterly report filed on October 28, 2025, an 8-K current report filed on April 23, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for IQVIA (IQV) (SEC CIK 1478242), with AI-powered section-by-section summaries updated daily.

10-Q: 39
10-K: 13
8-K: 3

Latest 2026 SEC Filing Dates

10-K Annual Report
Feb 17, 2026
10-Q Quarterly Report
Oct 28, 2025
8-K Current Report
Apr 23, 2026

AI 10-K Annual Report Analysis
Latest 10-K (2025-12-31)

Business Overview

  • Core business model: Global clinical development and commercial solutions services for biopharmaceutical industry
  • Emphasis on risks from client consolidation reducing service volumes and revenue loss post-mergers in clients’ industries
+3 more insights

Risk Factors

  • Regulatory risk: Compliance with HIPAA and EU GDPR, with potential fines and penalties under US Dept. of Health and Human Services and EU authorities
  • Geopolitical risk: Increased cyberattack threat from state-sponsored actors causing data compromise and operational disruption in global IT systems
+3 more insights

Management Discussion & Analysis

  • Revenue $16,310M in 2025, up 5.9% (+$905M) YoY; Technology & Analytics Solutions +7.6% ($466M), Research & Development Solutions +4.3% ($369M), Contract Sales & Medical Solutions +9.7% ($70M)
  • Operating profit $2,182M in 2025, down 0.9% from $2,202M in 2024; segment profit: Technology & Analytics $1,595M (+4.8%), R&D $1,873M (-3.9%), Contract Sales $48M (+2.1%)
+3 more insights

AI 10-Q Quarterly Report Analysis
Latest 10-Q (2025-09-30)

Risk Factors

  • No new or changed risk factors since 2024 Form 10-K
  • Continued exposure to regulatory risks in global healthcare compliance

Management Discussion & Analysis

  • Revenue $4,100M Q3 2025, up 5.2% YoY ($204M increase); Technology & Analytics +$52M, R&D +$73M, Contract Sales +$25M
  • Operating margin decreased: Segment profit $1,555M YTD, down 1.3% YoY ($21M); Technology & Analytics profit +1.6%, R&D profit -4.3%, Contract Sales profit +5.9%
Read full Q3 2025 10-Q analysis →

Annual Reports Archive
10-K

AI-powered analysis of IQVIA (IQV) 10-K annual reports filed with SEC EDGAR.

Quarterly Reports Archive
10-Q

AI-powered analysis of IQVIA (IQV) 10-Q quarterly reports filed with SEC EDGAR.

Financial Summary
XBRL

FY2022FY2023FY2024FY2025
Profitability
Revenue$14.4B$15.0B$15.4B$16.3B
Operating Income$1.8B$2.0B$2.2B$2.2B
Net Income$1.1B$1.4B$1.4B$1.4B
Op. Margin12.5%13.2%14.3%13.4%
Net Margin7.6%9.1%8.9%8.3%
Balance Sheet
Total Assets$25.3B$26.7B$26.9B$29.9B
Equity$5.8B$6.1B$6.1B$6.5B
ROE18.9%22.2%22.6%20.9%

Source: XBRL financial data from IQVIA (IQV) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.

Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4

FormFiling DatePeriodAnalysisSEC
8-K
Apr 23, 2026
10-K
Feb 17, 2026Dec 31, 2025Analysis
8-K
Feb 5, 2026
8-K
Dec 9, 2025
10-Q
Oct 28, 2025Sep 30, 2025Analysis
10-Q
Jul 22, 2025Jun 30, 2025
10-Q
May 6, 2025Mar 31, 2025Analysis
10-K
Feb 13, 2025Dec 31, 2024
10-Q
Oct 31, 2024Sep 30, 2024
10-Q
Jul 22, 2024Jun 30, 2024
10-Q
May 2, 2024Mar 31, 2024
10-K
Feb 15, 2024Dec 31, 2023
10-Q
Nov 1, 2023Sep 30, 2023
10-Q
Aug 1, 2023Jun 30, 2023
10-Q
Apr 28, 2023Mar 31, 2023
10-K
Feb 15, 2023Dec 31, 2022
10-Q
Oct 27, 2022Sep 30, 2022
10-Q
Jul 22, 2022Jun 30, 2022
10-Q
Apr 28, 2022Mar 31, 2022
10-K
Feb 16, 2022Dec 31, 2021
10-Q
Oct 22, 2021Sep 30, 2021
10-Q
Jul 28, 2021Jun 30, 2021
10-Q
Apr 23, 2021Mar 31, 2021
10-K
Feb 12, 2021Dec 31, 2020
10-Q
Oct 22, 2020Sep 30, 2020

Frequently Asked Questions

What are the latest IQV SEC filings in 2026?

IQVIA (IQV) has filed a 10-K annual report on February 17, 2026, a 10-Q quarterly report on October 28, 2025, an 8-K current report on April 23, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did IQV file its most recent 10-K annual report?

IQVIA (IQV) filed its most recent 10-K annual report on February 17, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view IQV 10-Q quarterly reports?

IQVIA (IQV)'s most recent 10-Q quarterly report was filed on October 28, 2025. SignalX displays every IQV 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has IQV filed recently?

IQVIA (IQV)'s most recent 8-K was filed on April 23, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find IQV insider trading activity (Form 4)?

SignalX aggregates every IQV Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does IQV file with the SEC?

IQVIA (IQV) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new IQV filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for IQVIA (IQV).

What is IQV's SEC CIK number?

IQVIA (IQV)'s SEC CIK (Central Index Key) number is 1478242. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1478242 to look up all IQV filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find IQV return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from IQVIA (IQV) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.

Stay on top of IQVIA SEC filings

Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 55+ filings.